Revised SPCs: Kevzara (sarilumab) injection – all products
Pneumonia and cellulitis added as uncommon (≥ 1/1,000 to < 1/100) adverse effects of treatment.
Source:
electronic Medicines compendium
Pneumonia and cellulitis added as uncommon (≥ 1/1,000 to < 1/100) adverse effects of treatment.
electronic Medicines compendium